H.C. Wainwright analyst Scott Buc adjusted the price target for Neurotrope (NASDAQ:NTRP) shares, raising it to $5.00 from the previous $2.50, while maintaining a Neutral rating on the stock. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback